Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-05-30
2006-05-30
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S361000
Reexamination Certificate
active
07053091
ABSTRACT:
In its many embodiments, the present invention provides a novel class of compounds as inhibitors of type 3 17β-hydroxysteroid dehydrogenase, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with type 3 17β-hydroxysteroid dehydrogenase using such compounds or pharmaceutical compositions.
REFERENCES:
patent: 6362188 (2002-03-01), Guzi et al.
patent: 6541463 (2003-04-01), Labrie et al.
patent: 1122242 (2001-08-01), None
patent: WO 86/01105 (1986-02-01), None
patent: WO 90/10462 (1990-09-01), None
patent: WO 91/00731 (1991-01-01), None
patent: WO 91/00733 (1991-01-01), None
patent: WO 94/26767 (1994-11-01), None
patent: WO 96/26201 (1996-08-01), None
patent: WO 97/11162 (1997-03-01), None
patent: WO 99/46279 (1999-09-01), None
patent: WO 9946279 (1999-09-01), None
patent: WO 03/022835 (2003-03-01), None
patent: WO 03/033487 (2003-04-01), None
patent: WO 2004/046111 (2004-06-01), None
Tsakovska, et al., “Molecular modeling of triazine type MDR modulators using CoMFA and CoMSIA approaches,” SAR and QSAR in Environmental Research , vol. 13, No. 3-4, pp. 473-484 (2002).
Copy of International Search Report for OC06001-01 (7pgs.).
Doll Ronald J.
Girijavallabhan Viyyoor M.
Guzi Timothy J.
Liu Yi-Tsung
Pachter Jonathan A.
Farquharson Serena I.
Freistein Andrew B.
Kalyanaraman Palaiyur S.
Schering Corporation
Shameem Golam M. M.
LandOfFree
17 β-hydroxysteroid dehydrogenase type 3 inhibitors... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 17 β-hydroxysteroid dehydrogenase type 3 inhibitors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 17 β-hydroxysteroid dehydrogenase type 3 inhibitors... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3630867